Centre for Infectious Diseases and Microbiology and NHMRC Clinical Centre for Research Excellence in Bioethics and Haematological Malignancies, Westmead Hospital, Westmead, New South Wales, Australia.
Bone Marrow Transplant. 2010 Apr;45(4):656-61. doi: 10.1038/bmt.2009.209. Epub 2009 Aug 17.
To prevent respiratory virus (RV) infection after hematopoietic SCT (HSCT), patient and household members are advised to have annual influenza vaccinations and avoid symptomatic contacts. The object of this study was to measure and increase patient/household awareness of RV infection and preventive measures. We used a self-administered questionnaire before/after a 5-min educational module (2006-2007) and interviews with HSCT patients (2005-2007). The subjects were patients and their households attending pre-HSCT education in an Australian HSCT Unit. Outcome measures were awareness of RV infection post-HSCT and effective prevention strategies; household influenza vaccination on admission for HSCT. In all, 139 out of 205 (68%) participants completed both questionnaires. Baseline knowledge of RV infection risk was high; knowledge of prevention was low. Intervention increased awareness that influenza post-HSCT could be fatal or require intensive care (68-87%, P=0.003), knowledge of effective prevention strategies (41-78%, P<0.0001) including vaccination (11-58%, P<0.0001), and belief among family/friends (but not patients) that household vaccination reduces influenza risk post-HSCT (57-97%, P<0.0001 and 76-81%, P=0.2, respectively). Household vaccination at HSCT admission was 71% for attenders and 30% for non-participants (RR 2.38, 95% confidence interval (CI) 1.49-3.80, P<0.0001). We concluded that patient and family pre-HSCT education increases awareness of RV prevention strategies and household influenza vaccination.
为了预防造血干细胞移植(HSCT)后呼吸道病毒(RV)感染,建议患者和家庭成员每年接种流感疫苗并避免与有症状的人接触。本研究的目的是测量并提高患者/家庭对 RV 感染和预防措施的认识。我们在澳大利亚 HSCT 单位的 HSCT 前教育中使用了 5 分钟教育模块(2006-2007 年)前后的自我管理问卷和对 HSCT 患者的访谈(2005-2007 年)。研究对象是参加澳大利亚 HSCT 单位 HSCT 前教育的患者及其家属。主要观察指标为 HSCT 后对 RV 感染和有效预防策略的认识;HSCT 入院时家庭流感疫苗接种情况。共有 205 名参与者中的 139 名完成了两份问卷。RV 感染风险的基线知识水平较高;预防知识水平较低。干预措施提高了对 HSCT 后流感可能致命或需要重症监护的认识(68%-87%,P=0.003),提高了对有效预防策略的认识(41%-78%,P<0.0001),包括接种疫苗(11%-58%,P<0.0001),以及家人/朋友(而非患者)认为家庭接种疫苗可降低 HSCT 后流感风险(57%-97%,P<0.0001 和 76%-81%,P=0.2,分别)。参加者的家庭接种率为 71%,非参与者的家庭接种率为 30%(RR 2.38,95%置信区间(CI)1.49-3.80,P<0.0001)。我们得出结论,HSCT 前患者和家庭教育可提高对 RV 预防策略和家庭流感疫苗接种的认识。